Results 41 to 50 of about 747,115 (360)

An Exploration of the Treatment of Non-Alcoholic Fatty Liver Disease Based on Dietary Factors [PDF]

open access: yesBIO Web of Conferences
Non-alcoholic fatty liver disease is a clinical pathological syndrome characterized by diffuse hepatocellular macrovesicular steatosis caused by other liver-damaging factors except for alcohol.
Yang Wanzhou
doaj   +1 more source

RNA interference against discoidin domain receptor 2 ameliorates alcoholic liver disease in rats. [PDF]

open access: yesPLoS ONE, 2013
Discoidin domain receptor 2 (DDR2) is involved in fibrotic disease. However, the exact pathogenic implications of the receptor in early alcoholic liver disease are still controversial.
Zheng Luo   +6 more
doaj   +1 more source

Oxidative stress: new insights on the association of nonalcoholic fatty liver disease and atherosclerosis [PDF]

open access: yes, 2015
Non-alcoholic fatty liver disease (NAFLD) represents the most common and emerging chronic liver disease worldwide. It includes a wide spectrum of liver diseases ranging from simple fatty liver to non-alcoholic steatohepatitis (NASH), which may progress ...
Albanese, Fabiana   +7 more
core   +1 more source

The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study.

open access: yesRevista da Associação Médica Brasileira, 2021
OBJECTIVE Non-alcoholic fatty liver disease, which is characterized by lipid being deposited into hepatocytes, affects nearly one in three adults globally. Inflammatory markers were suggested to be related with hepatic steatosis.
Mehmet Ali Kosekli   +7 more
semanticscholar   +1 more source

Role of High-Mobility Group Box-1 in Liver Pathogenesis [PDF]

open access: yes, 2019
High-mobility group box 1 (HMGB1) is a highly abundant DNA-binding protein that can relocate to the cytosol or undergo extracellular release during cellular stress or death. HMGB1 has a functional versatility depending on its cellular location.
Huda, Nazmul   +3 more
core   +1 more source

Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation [PDF]

open access: yesArquivos de Gastroenterologia, 2001
Background — Non-alcoholic steatohepatitis was coined in 1980 to describe pathological and clinical features of non-alcoholic disease associated with pathological features, commonly seen in alcoholic-liver disease itself.
Raquel F. Liermann GARCIA   +5 more
doaj   +1 more source

The use of ultrasound in clinical setting for children affected by NAFLD. is it safe and accurate? [PDF]

open access: yes, 2011
Non-alcoholic fatty liver disease (NAFLD) has become over the last decade the most common form of chronic liver disease in children and adults. Thus, establishing the diagnosis of NAFLD is of utmost importance and represents a major challenge as the ...
Alisi A   +4 more
core   +3 more sources

Iron and steatohepatitis. [PDF]

open access: yes, 2012
As the main iron storage site in the body and the main source of the iron-regulatory hormone, hepcidin, the liver plays a pivotal role in iron homeostasis.
Amato   +49 more
core   +1 more source

The effect of  the  products of  ethanol metabolism on the  liver – a  review

open access: yesAlcoholism and Drug Addiction, 2019
The consequences of consuming excessive amounts of alcoholic beverages are currently an important problem for many societies, not only in the context of treatment of alcohol dependence, but also the health effects of alcohol abuse.
Aleksandra Kołota
doaj   +1 more source

Statins and non-alcoholic fatty liver disease [PDF]

open access: yes, 2019
Dear Editor, In April 9 issue, van den Berg et al1 report interesting results on the indication for lipid‐lowering treatment in a large cohort with suspected non‐alcoholic fatty liver disease (NAFLD) within the population‐based Lifelines Cohort Study.
Angelico, F   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy